Voyageur Pharmaceuticals (CVE:VM) Shares Up 50% – Should You Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report)’s share price rose 50% during mid-day trading on Wednesday . The company traded as high as C$0.11 and last traded at C$0.11. Approximately 1,942,446 shares were traded during mid-day trading, an increase of 1,795% from the average daily volume of 102,479 shares. The stock had previously closed at C$0.07.

Voyageur Pharmaceuticals Stock Up 50.0 %

The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84. The stock has a market cap of C$14.64 million, a price-to-earnings ratio of -10.50 and a beta of 0.32. The firm’s 50-day moving average is C$0.07 and its 200 day moving average is C$0.06.

About Voyageur Pharmaceuticals

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Read More

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.